Our study also showed that overexpression of USP10 inhibited the malignant biological behavior of DOX-resistant thyroid cancer cells, while concomitant overexpression of ABCG2 reversed this inhibition caused by USP10. This evidence concerns the gene USP10 and thyroid gland carcinoma.